Kenai Therapeutics

Biotechnology Research • San Diego, California, United States • 21-50 Employees

Company overview

Headquarters	San Diego, California, United States
Phone number	+18155056466
Website	kenaitx.com
NAICS	541714
Employees	21-50
Socials

Key Contacts at Kenai Therapeutics

Travis Cordie

Associate Director Of Gmp Manufacturing

Stephen Federowicz

Director Of Bioinformatics

Duke Ohashi

Director Clinical Operations

Anton Bittner

Program Director

Carrie Chavez

Associate Director Of Cmc Program Operations

Anindita Bhoumik

Senior Director || Kenai Therapeutics || Cell Therapy Research And Development

Jenny Hong Gonzalez

Director, Intellectual Property & Legal

Kenai Therapeutics Email Formats

Kenai Therapeutics uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@kenaitx.com), used 100% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@kenaitx.com	100%

About Kenai Therapeutics

Kenai Therapeutics (Kenai) is a biotechnology company pioneering next generation approaches to cure neurological conditions. The Company utilizes induced pluripotent stem cell (iPSC) technology, a Nobel Prize-winning breakthrough that enables scientists to manufacture any human cell, to generate Kenai’s off-the-shelf neuron replacement therapeutics. By focusing on an iPSC technology platform, and forging partnerships with global leaders in surgical delivery and clinical development, Kenai is dedicated to advancing a best-in-class pipeline targeting neurological conditions. Kenai Therapeutics closed an $82 million Series A financing in 2024, co-led by Alaska Permanent Fund Corporation, Cure Ventures and The Column Group, with participation from Euclidean Capital and Saisei Ventures. For additional information, please visit: www.kenaitx.com.

Kenai Therapeutics revenue & valuation

Annual revenue	$2,481,095
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$8,000,000
Total funding	$86,000,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director

C-Suite

Entry

Employees by Department

Kenai Therapeutics has 10 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Kenai Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-03-14	9	$4,000,000
2024-03-29	4	$82,000,000

Funding Insights

$86,000,000

Total funding amount

$82,000,000

Most recent funding amount

Number of funding rounds

Kenai Therapeutics Tech Stack

Discover the technologies and tools that power Kenai Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

Emotion

Development

Lodash

JavaScript libraries

reCAPTCHA

Security

Squarespace Commerce

Ecommerce

Stimulus

JavaScript frameworks

HSTS

Security

Open Graph

Miscellaneous

core-js

JavaScript libraries

Cart Functionality

Ecommerce

YUI

JavaScript libraries

Squarespace

CMS

Frequently asked questions

Kenai Therapeutics is located in San Diego, California, US.

You can reach Kenai Therapeutics at +18155056466.

Kenai Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Kenai Therapeutics has raised a total of $86,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Kenai Therapeutics

Travis Cordie

Associate Director Of Gmp Manufacturing

Stephen Federowicz

Director Of Bioinformatics

Duke Ohashi

Director Clinical Operations

Anton Bittner

Program Director

Carrie Chavez

Associate Director Of Cmc Program Operations

Anindita Bhoumik